Learning Objectives:

1. To review latest mechanisms and signaling aberrations associated with cavernous angiomas pathogenesis.

2. To present the concept of cavernous angiomas with symptomatic hemorrhage (CASH) and its biomarkers and therapeutic targets.

3. To analyze common genes, biomarkers and potential therapies of cavernous angioma and their application for the aging Neurovascular Unit.

Session date: 
Wednesday, March 11, 2020 - 8:30am to 9:30am
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Issam A. Awad, MD, MSc, FACS, MA (hon)